This paper is in the following e-collection/theme issue:

Reviews in Dermatology (43) Diabetes (284) Glucose Tracking and Self-Monitoring of Blood Glucose (206) Apps, Mobile, Wearables for Diabetes (373) Patient Experiences with Diabetes Technology (50) Medical Devices for Insulin and Metabolic Peptide Delivery (4)

Published on in Vol 7 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/59824, first published .
Cutaneous Adverse Effects From Diabetes Devices in Pediatric Patients With Type 1 Diabetes Mellitus: Systematic Review

Cutaneous Adverse Effects From Diabetes Devices in Pediatric Patients With Type 1 Diabetes Mellitus: Systematic Review

Cutaneous Adverse Effects From Diabetes Devices in Pediatric Patients With Type 1 Diabetes Mellitus: Systematic Review

Authors of this article:

Alicia Podwojniak1 Author Orcid Image ;   Joseph Flemming1 Author Orcid Image ;   Isabella J Tan2 Author Orcid Image ;   Hira Ghani3 Author Orcid Image ;   Zachary Neubauer4 Author Orcid Image ;   Anne Jones1 Author Orcid Image
Article Authors Cited by (6) Tweetations Metrics

Journals

  1. Dorati R, Cosco D, Battaglia L, Cirri M, Conti B, Borghi T, Gabriele M, Bruno G, Rocco P, Selmin F, Maestrelli F. On-body drug delivery systems: State-of-the-art technologies, clinical application, and future perspectives. Drug Discovery Today 2025;30(9):104441 View
  2. Lee S, Carlberg V, Todd P, Schmidt B, Garza‐Mayers A, Ho T. Continuous Subcutaneous Insulin Infusion (CSII)‐Associated Granulomatous Suppurative Reaction in Four Children With Type 1 Diabetes. Pediatric Dermatology 2025 View
  3. Alsuwaidi L, Kanj L, Rowaiaee R, Kanj S, Otaki F, Otypi W, Bejjani M. A call to combat the burden of Allergic Contact Dermatitis among children and adolescents with type 1 diabetes mellitus using medical adhesives: a cross-sectional observational study. Frontiers in Clinical Diabetes and Healthcare 2025;6 View
  4. Hrubá E, Kubíček J, Augustynek M. Scoping review of subcutaneous glucose monitoring techniques. Measurement 2026;261:119940 View
  5. Bruttomesso D, Petrie J, Evans M, Fleming G, Hanaire H, Holl R, Sherr J, Bergenstal R, Heinemann L, Peters A. Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. Diabetologia 2026 View

Books/Policy Documents

  1. Markakis K, Vazeou A. Encyclopedia of Endocrine Diseases. View